136 results on '"Nouta, Jan"'
Search Results
2. Human Prostate-Specific Antigen Carries N-Glycans with Ketodeoxynononic Acid
3. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
4. Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
5. Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry
6. High-throughput glycopeptide profiling of prostate-specific antigen from seminal plasma by MALDI-MS
7. IgG1 glycosylation highlights premature aging in Down syndrome.
8. Biological and structural characterization of murine TRALI antibody reveals increased Fc-mediated complement activation
9. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination
10. Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines
11. Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages.
12. Factors affecting IgG4-mediated complement activation
13. Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages
14. Factors affecting IgG4-mediated complement activation
15. Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples
16. Factors affecting IgG4-mediated complement activation
17. mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
18. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees
19. Phagocytosis of platelets opsonized with differently glycosylated anti-HLA hIgG1 by monocyte-derived macrophages
20. Immunoassay for quantification of antigen-specific IgG fucosylation
21. Immunoassay for quantification of antigen-specific IgG fucosylation
22. Immunoglobulin G1 Fc glycosylation as an early hallmark of severe COVID-19
23. Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
24. The BNT162b2 mRNA SARS-CoV-2 Vaccine Induces Transient Afucosylated IgG1 in Naive But Not in Antigen-Experienced Vaccinees
25. mRNA vaccines against SARSCoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine.
26. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets
27. Association of Antibody-Dependent Neutrophil Phagocytosis With Distinct Antibody Glycosylation Profiles Following Typhoid Vaccination
28. Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation
29. The IgG glycome of SARS-CoV-2 infected individuals reflects disease course and severity.
30. High titers and low fucosylation of early human anti–SARS-CoV-2 IgG promote inflammation by alveolar macrophages
31. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
32. Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry
33. Large-Scale Analysis of Apolipoprotein CIII Glycosylation by Ultrahigh Resolution Mass Spectrometry
34. Afucosylated Plasmodium falciparum-specific IgG is induced by infection but not by subunit vaccination
35. Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification
36. Capillary Electrophoresis-Mass Spectrometry at Trial by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible and Robust Compound Annotation
37. Serum N‐Glycome analysis reveals pancreatic cancer disease signatures
38. A Matrix-Assisted Laser Desorption/Ionization—Mass Spectrometry Assay for the Relative Quantitation of Antennary Fucosylated N-Glycans in Human Plasma
39. Chemically synthesized protein as tumour-specific vaccine: immunogenicity and efficacy of synthetic HPV16 E7 in the TC-1 mouse tumour model
40. Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples
41. An In-Depth Glycosylation Assay for Urinary Prostate-Specific Antigen
42. Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
43. Quantification of serum apolipoproteins A-I and B-100 in clinical samples using an automated SISCAPA–MALDI-TOF-MS workflow
44. Oxidative Stress in Complex Regional Pain Syndrome (CRPS): No Systemically Elevated Levels of Malondialdehyde, F2-Isoprostanes and 8OHdG in a Selected Sample of Patients
45. Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection
46. Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
47. Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection
48. Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell Therapy
49. Immune Complex-Loaded Dendritic Cells Are Superior to Soluble Immune Complexes as Antitumor Vaccine
50. Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.